跳至主要内容
临床试验/NCT06879925
NCT06879925招募中不适用

The Effects of Qi-gong on Physiology and Quality of Life in Patients with Post-acute Sequelae of Covid-19

POCHIWU2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年12月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80
试验地点
2
主要终点
Heart rate variability

研究概览

简要总结

The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).

Study Objectives:

To assess whether Qi-Gong improves physiological function in individuals with PASC.

To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.

Study Design:

If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness.

Participant Involvement:

Practice Qi-Gong three times per week for three months. Record physiological data monthly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
20 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •above 20 y/o

排除标准

  • •Those who cannot cooperate
  • •Severe schizophrenia

研究组 & 干预措施

Qi-Gong Group

Experimental

Experimental Group :Qi-Gong(yijinjing)

干预措施: QI-GONG and control (Behavioral)

routine care Group

No Intervention

Control Group:routine care

结局指标

主要结局

Heart rate variability

时间窗: From enrollment to the end of treatment at 12 weeks

Low Frequency,40%-60%

Pulmonary Function Test (Forced vital capacity)

时间窗: From enrollment to the end of treatment at 12 weeks

FVC,over 80% is better

Quality of Life(The short version of the World Health Organization Quality of Life ,WHOQOL-BREF)

时间窗: From enrollment to the end of treatment at 12 weeks

WHOQOL-BREF 4 domains,and each one score is 4 - 20. more score more better

Pulmonary Function Test (FEV1)

时间窗: From enrollment to the end of treatment at 12 weeks

FEV1,over 80% is better

Pulmonary Function Test (FVCFEV1)

时间窗: From enrollment to the end of treatment at 12 weeks

FVCFEV1,over 80% is better

次要结局

未报告次要终点

研究者

发起方
POCHIWU
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

POCHIWU

nurse、master's candidate

National Taipei University of Nursing and Health Sciences

研究点 (2)

Loading locations...

相似试验